Ondansetron for the treatment of irritable bowel syndrome (IBS) with diarrhoea (IBS-D): identifying the responder

Not Applicable

Completed

• Conditions: Topic: Primary Care Research Network for England; Subtopic: Not Assigned; Disease: All Diseases; Digestive System; Irritable bowel syndrome

• Registration Number: ISRCTN22664524
• Lead Sponsor: niversity of Nottingham (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-03-31
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1. Patients with IBS-D meeting the Rome III criteria
2. Patients able to give informed consent
3. Female patients of child bearing potential are willing to use at least one highly effective contraceptive method
4. Aged 18 years and over, either sex

Exclusion Criteria

1. Women who are pregnant or breast feeding
2. Patients unable to stop anti-diarrhoeal drugs
3. Patients currentluy in, or have been in another clinical trial in the previous 3 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified